Fiche publication
Date publication
mars 2019
Journal
Pediatric blood & cancer
Auteurs
Lien Pubmed
Résumé
To investigate the antitumor activity of a four-drug metronomic chemotherapy (MC) regimen in relapsed/progressing pediatric extracranial solid tumors (EST). The primary objective was clinical benefit (complete response /partial response/stable disease [SD]) after two cycles of therapy (four months).
Référence
Pediatr Blood Cancer. 2019 Mar 28;:e27693
